Reyon Pharmaceutical Co Ltd (102460) — Cash Flow Reinvestment Rate
Reyon Pharmaceutical Co Ltd (102460) has a Cash Flow Reinvestment Rate of 1.76x as of March 2025, reinvesting ₩4.25 Billion (capex ₩4.25 Billion plus investments ₩6.04 Million) from operating cash flow of ₩2.41 Billion. Explore Reyon Pharmaceutical Co Ltd (102460) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Reyon Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2008–2023)
Historical reinvestment intensity for Reyon Pharmaceutical Co Ltd across 11 annual periods. Also explore Reyon Pharmaceutical Co Ltd (102460) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Reyon Pharmaceutical Co Ltd (2008–2023)
Year-by-year capital reinvestment analysis for Reyon Pharmaceutical Co Ltd. For live market cap and broader valuation context, see Reyon Pharmaceutical Co Ltd (102460) total market value.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 5.65x | ₩48.85 Billion | ₩8.65 Billion | ₩28.87 Billion | ▼ -57.4% |
| 2022 | 13.25x | ₩115.70 Billion | ₩8.73 Billion | ₩63.13 Billion | ▲ +30.1% |
| 2021 | 10.19x | ₩119.05 Billion | ₩11.68 Billion | ₩116.98 Billion | ▼ -37.1% |
| 2020 | 16.20x | ₩74.53 Billion | ₩4.60 Billion | ₩52.31 Billion | ▲ +120.5% |
| 2018 | 7.35x | ₩84.12 Billion | ₩11.45 Billion | ₩39.17 Billion | ▲ +144.8% |
| 2017 | 3.00x | ₩50.32 Billion | ₩16.76 Billion | ₩4.14 Billion | ▲ +186.4% |
| 2016 | 1.05x | ₩9.93 Billion | ₩9.47 Billion | ₩3.21 Billion | ▲ +334.7% |
| 2012 | 0.24x | ₩5.94 Billion | ₩24.65 Billion | ₩2.42 Billion | ▼ -37.8% |
| 2011 | 0.39x | ₩5.94 Billion | ₩15.34 Billion | ₩2.42 Billion | ▼ -1.2% |
| 2009 | 0.39x | ₩3.40 Billion | ₩8.68 Billion | ₩1.46 Billion | ▼ -41.6% |
| 2008 | 0.67x | ₩4.01 Billion | ₩5.99 Billion | ₩2.06 Billion | — |